EX-32.2 7 knsa-20240331xex32d2.htm EX-32.2

Exhibit 32.2

​

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

​

I, Mark Ragosa, Chief Financial Officer of Kiniksa Pharmaceuticals, Ltd. (the “Company”), hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

​

(1) The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

​

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

​ | ​
April 25, 2024 | /s/ Mark Ragosa
​ | Mark Ragosa
​ | Chief Financial Officer (Principal Financial Officer)
​ | ​

​